BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32444178)

  • 1. Chromophobe renal cell carcinoma: New genetic and metabolic insights.
    Zhang L; Henske EP
    Urol Oncol; 2020 Aug; 38(8):678-681. PubMed ID: 32444178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276).
    Yang Y; Vocke CD; Ricketts CJ; Wei D; Padilla-Nash HM; Lang M; Sourbier C; Killian JK; Boyle SL; Worrell R; Meltzer PS; Ried T; Merino MJ; Metwalli AR; Linehan WM
    Genes Chromosomes Cancer; 2017 Oct; 56(10):719-729. PubMed ID: 28736828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma.
    Priolo C; Khabibullin D; Reznik E; Filippakis H; Ogórek B; Kavanagh TR; Nijmeh J; Herbert ZT; Asara JM; Kwiatkowski DJ; Wu CL; Henske EP
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6274-E6282. PubMed ID: 29891694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
    Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
    Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity to ferroptosis in chromophobe RCC is mediated by a glutathione metabolic dependency and cystine import via solute carrier family 7 member 11.
    Zhang L; Hobeika CS; Khabibullin D; Yu D; Filippakis H; Alchoueiry M; Tang Y; Lam HC; Tsvetkov P; Georgiou G; Lamb C; Stone E; Puigserver P; Priolo C; Henske EP
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2122840119. PubMed ID: 35867762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive review of chromophobe renal cell carcinoma.
    Garje R; Elhag D; Yasin HA; Acharya L; Vaena D; Dahmoush L
    Crit Rev Oncol Hematol; 2021 Apr; 160():103287. PubMed ID: 33753250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
    Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R; Bottaro DP; Choueiri TK; Gibbs RA; Godwin AK; Haake S; Hakimi AA; Henske EP; Hsieh JJ; Ho TH; Kanchi RS; Krishnan B; Kwiatkowski DJ; Liu W; Merino MJ; Mills GB; Myers J; Nickerson ML; Reuter VE; Schmidt LS; Shelley CS; Shen H; Shuch B; Signoretti S; Srinivasan R; Tamboli P; Thomas G; Vincent BG; Vocke CD; Wheeler DA; Yang L; Kim WY; Robertson AG; ; Spellman PT; Rathmell WK; Linehan WM
    Cell Rep; 2018 Apr; 23(1):313-326.e5. PubMed ID: 29617669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
    Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
    Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
    Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
    Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
    Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
    Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset.
    Baraban EG; Elias R; Lin MT; Ged Y; Zhu J; Pallavajjala A; Singla N; Lotan TL; Argani P; Eshleman JR; Epstein JI
    Mod Pathol; 2024 May; 37(5):100472. PubMed ID: 38492778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer.
    Abbosh P; Sundararajan S; Millis SZ; Hauben A; Reddy S; Geynisman DM; Uzzo R
    Eur Urol Focus; 2018 Dec; 4(6):969-971. PubMed ID: 28753842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.
    Ahmed EA; Youssif ME
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocytosis-Mediated Replenishment of Amino Acids Favors Cancer Cell Proliferation and Survival in Chromophobe Renal Cell Carcinoma.
    Xiao Y; Rabien A; Buschow R; Amtislavskiy V; Busch J; Kilic E; Villegas SL; Timmermann B; Schütte M; Mielke T; Yaspo ML; Jung K; Meierhofer D
    Cancer Res; 2020 Dec; 80(24):5491-5501. PubMed ID: 33115803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms.
    Petit A; Castillo M; Santos M; Mellado B; Alcover JB; Mallofré C
    Am J Surg Pathol; 2004 May; 28(5):676-8. PubMed ID: 15105658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.
    Li L; Chen X; Hao L; Chen Q; Liu H; Zhou Q
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32662515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including Its Variant Morphologies.
    Alaghehbandan R; Trpkov K; Tretiakova M; Luis AS; Rogala JD; Hes O
    Adv Anat Pathol; 2021 Jan; 28(1):8-20. PubMed ID: 33021507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromophobe renal cell carcinoma.
    Henske EP; Cheng L; Hakimi AA; Choueiri TK; Braun DA
    Cancer Cell; 2023 Aug; 41(8):1383-1388. PubMed ID: 37541245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
    Wu H; Fan L; Liu H; Guan B; Hu B; Liu F; Hocher B; Yin L
    Biomed Res Int; 2020; 2020():4030915. PubMed ID: 31998788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.